GUEST COLUMNISTS

• Your EDC Query Count Is Trying To Tell You Something

  A rising EDC query count may reveal more than dirty data. Learn how query patterns can expose upstream problems in trial workflows, training, and CRF design.

• Can A Universal Health Screening Help Stop Clinical Trial Dropouts?

  Could comprehensive health scans give trial participants meaningful value — and help sponsors reduce costly dropouts?

• Can Your Team Coordinate The CRO Model You've Chosen?

  Choosing the right CRO model matters less than a sponsor’s ability to coordinate it. Here’s how to match outsourcing strategy to internal capacity.

• To Pick The Right Medical LLM, First Assess Your Readiness

  Learn how to evaluate medical LLMs for clinical trials by weighing readiness, risk, validation, integration, hidden costs, and supplier controls.

• Your Company Needs Compliance Expertise — But When And From Whom?

  When should a biotech formalize compliance? Learn how risk, funding, clinical activity, and commercialization shape the right expertise and structure.

• 5 Sponsor Contracting Issues That Delay Clinical Trials — And How To Avoid Them

  CTA negotiations don’t have to stall study start-up. Learn five sponsor-side contracting issues that cause delays and practical ways to prevent them.

• Participant Payment — Make It Make Cents

  Participant payment practices and expectations vary wildly. With advocate T.J. Sharpe, explore why sponsors need to rethink how they appreciate participants' time, effort, and burden.

• What Ecological Momentary Assessment Taught Us About Real-World Hearing Outcomes

  Ecological momentary assessment (EMA) reveals how people experience hearing challenges beyond the clinic. Here, researchers highlight its relevance in designing real-world hearing studies.